Table of Contents

Executive Summary

1 Industry Overview of Pregabalin

• 1.1 Definition of Pregabalin
• 1.2 Pregabalin Segment by Type
  • 1.2.1 Global Pregabalin Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Epilepsy
  • 1.2.3 Neuropathic Pain
  • 1.2.4 Fibromyalgia
  • 1.2.5 Generalized Anxiety Disorder
• 1.3 Pregabalin Segment by Applications
  • 1.3.1 Global Pregabalin Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Research Institutes
  • 1.3.3 Pharmaceutical Companies
  • 1.3.4 Others (Hospitals and Clinics)
• 1.4 Global Pregabalin Overall Market
  • 1.4.1 Global Pregabalin Revenue (2014-2025)
  • 1.4.2 Global Pregabalin Production (2014-2025)
  • 1.4.3 North America Pregabalin Status and Prospect (2014-2025)
  • 1.4.4 Europe Pregabalin Status and Prospect (2014-2025)
  • 1.4.5 China Pregabalin Status and Prospect (2014-2025)
  • 1.4.6 Japan Pregabalin Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Pregabalin Status and Prospect (2014-2025)
  • 1.4.8 India Pregabalin Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Pregabalin
• 2.3 Manufacturing Process Analysis of Pregabalin
• 2.4 Industry Chain Structure of Pregabalin

3 Development and Manufacturing Plants Analysis of Pregabalin

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Pregabalin Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Pregabalin
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Pregabalin Production and Capacity Analysis
• 4.2 Pregabalin Revenue Analysis
• 4.3 Pregabalin Price Analysis
• 4.4 Market Concentration Degree

5 Pregabalin Regional Market Analysis

• 5.1 Pregabalin Production by Regions
  • 5.1.1 Global Pregabalin Production by Regions
  • 5.1.2 Global Pregabalin Revenue by Regions
• 5.2 Pregabalin Consumption by Regions
• 5.3 North America Pregabalin Market Analysis
  • 5.3.1 North America Pregabalin Production
  • 5.3.2 North America Pregabalin Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Pregabalin Import and Export
• 5.4 Europe Pregabalin Market Analysis
  • 5.4.1 Europe Pregabalin Production
  • 5.4.2 Europe Pregabalin Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Pregabalin Import and Export
• 5.5 China Pregabalin Market Analysis
  • 5.5.1 China Pregabalin Production
  • 5.5.2 China Pregabalin Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Pregabalin Import and Export
• 5.6 Japan Pregabalin Market Analysis
  • 5.6.1 Japan Pregabalin Production
  • 5.6.2 Japan Pregabalin Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Pregabalin Import and Export
• 5.7 Southeast Asia Pregabalin Market Analysis
  • 5.7.1 Southeast Asia Pregabalin Production
  • 5.7.2 Southeast Asia Pregabalin Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Pregabalin Import and Export
• 5.8 India Pregabalin Market Analysis
  • 5.8.1 India Pregabalin Production
  • 5.8.2 India Pregabalin Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Pregabalin Import and Export

6 Pregabalin Segment Market Analysis (by Type)

• 6.1 Global Pregabalin Production by Type
• 6.2 Global Pregabalin Revenue by Type
• 6.3 Pregabalin Price by Type

7 Pregabalin Segment Market Analysis (by Application)

• 7.1 Global Pregabalin Consumption by Application
• 7.2 Global Pregabalin Consumption Market Share by Application (2014-2019)

8 Pregabalin Major Manufacturers Analysis

• 8.1 Pfizer Inc.
  • 8.1.1 Pfizer Inc. Pregabalin Production Sites and Area Served
  • 8.1.2 Pfizer Inc. Product Introduction, Application and Specification
  • 8.1.3 Pfizer Inc. Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Torrent Pharmaceuticals Ltd.
  • 8.2.1 Torrent Pharmaceuticals Ltd. Pregabalin Production Sites and Area Served
  • 8.2.2 Torrent Pharmaceuticals Ltd. Product Introduction, Application and Specification
  • 8.2.3 Torrent Pharmaceuticals Ltd. Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Lupin Limited
  • 8.3.1 Lupin Limited Pregabalin Production Sites and Area Served
  • 8.3.2 Lupin Limited Product Introduction, Application and Specification
  • 8.3.3 Lupin Limited Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Zydus Cadila Healthcare Ltd.
  • 8.4.1 Zydus Cadila Healthcare Ltd. Pregabalin Production Sites and Area Served
  • 8.4.2 Zydus Cadila Healthcare Ltd. Product Introduction, Application and Specification
  • 8.4.3 Zydus Cadila Healthcare Ltd. Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Cipla Limited
  • 8.5.1 Cipla Limited Pregabalin Production Sites and Area Served
  • 8.5.2 Cipla Limited Product Introduction, Application and Specification
  • 8.5.3 Cipla Limited Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Genesis Remedies
  • 8.6.1 Genesis Remedies Pregabalin Production Sites and Area Served
  • 8.6.2 Genesis Remedies Product Introduction, Application and Specification
  • 8.6.3 Genesis Remedies Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sanofi
  • 8.7.1 Sanofi Pregabalin Production Sites and Area Served
  • 8.7.2 Sanofi Product Introduction, Application and Specification
  • 8.7.3 Sanofi Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Medley Pharmaceuticals Limited
  • 8.8.1 Medley Pharmaceuticals Limited Pregabalin Production Sites and Area Served
  • 8.8.2 Medley Pharmaceuticals Limited Product Introduction, Application and Specification
  • 8.8.3 Medley Pharmaceuticals Limited Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Genesis Biotec Inc.
  • 8.9.1 Genesis Biotec Inc. Pregabalin Production Sites and Area Served
  • 8.9.2 Genesis Biotec Inc. Product Introduction, Application and Specification
  • 8.9.3 Genesis Biotec Inc. Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Biomax
  • 8.10.1 Biomax Pregabalin Production Sites and Area Served
  • 8.10.2 Biomax Product Introduction, Application and Specification
  • 8.10.3 Biomax Pregabalin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Pregabalin Market

• 9.1 Global Pregabalin Market Trend Analysis
  • 9.1.1 Global Pregabalin Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Pregabalin Regional Market Trend
  • 9.2.1 North America Pregabalin Forecast 2019-2025
  • 9.2.2 Europe Pregabalin Forecast 2019-2025
  • 9.2.3 China Pregabalin Forecast 2019-2025
  • 9.2.4 Japan Pregabalin Forecast 2019-2025
  • 9.2.5 Southeast Asia Pregabalin Forecast 2019-2025
  • 9.2.6 India Pregabalin Forecast 2019-2025
• 9.3 Pregabalin Market Trend (Product Type)
• 9.4 Pregabalin Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Pregabalin Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 

The global Pregabalin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pregabalin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pregabalin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pregabalin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pregabalin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer Inc.
Torrent Pharmaceuticals Ltd.
Lupin Limited
Zydus Cadila Healthcare Ltd.
Cipla Limited
Genesis Remedies
Sanofi
Medley Pharmaceuticals Limited
Genesis Biotec Inc.
Biomax

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Epilepsy
Neuropathic Pain
Fibromyalgia
Generalized Anxiety Disorder

Segment by Application
Research Institutes
Pharmaceutical Companies
Others (Hospitals and Clinics)